The office, people and counterparty names on this page are hidden. Create a free account to reveal 5 records a month, or get Family Office Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

A••••

Single family office (confirmed)Top 500· Holzkirchen

Single family office (confirmed), based in Holzkirchen, with 5 direct investments on record.

Composed from this office's classification, location and record.

Direct investments
5
Deal announcements, Form D and filings
Decision makers
1 of 4
The office's site, Form ADV Schedule A and filings
Last deployment
Nov 2025
The latest dated investment or commitment on record
Contact decision makersFind similar offices
1 export, up to 5 contact reveals
More
As of · the latest observation of this office; filed figures carry their own filing dates

What matters now

  1. 2
    direct deals, 12 months

    Latest direct deals: A••••••••• B•• (gene therapy, growth, Nov 2025), A••••••••• (Nov 2025) and F••••••• A• (biosimilars, growth, led, May 2022).

    What it bought last is the best guide to what it will buy next, and to the check it writes.

    Factannounced deals, press and filingsFor Founders and sponsors raising equityAll direct i•••••••••
  2. +13
    new co-investors, 12 months

    First deal alongside 13 new co-investors in 12 months: F•••••• on A••••••••• B••, A•••• V•••••• on A••••••••• B•• and S•••••••• C•••••• on A••••••••• B•• and 10 more.

    Who it now invests alongside is who will bring it the next deal, and who a sponsor can call for an introduction.

    Factparties named on its announced dealsFor Sponsors, co-investorsCo-investors
Readings, classification basis and verificationidentity confidence 85% · 23 observations · 2 sourcesShow
Single family office (confirmed)Verified Sep 16, 2026 (7 days ago)4 people · 5 investments · 0 public positions · 9 events

Why this class: Wikipedia, independent of the GlobeNewswire A••••••••• source, confirms Athos KG is the single family office of twin brothers T••••• and A•••••• S•••••••••, who built and sold the pharmaceutical company Hexal..

Direct investing
70
high
Co-investment
100
high

Each reading is 0 to 100 from the listed components in the evidence section; hover a tile for what it measures. No evidence yet of: external managers, private markets, sponsor-friendly, real estate.

Profile completeness 53% (high value, high value deep; the most valuable missing fact is contacts)
identityclassificationwealth origincapital-scale evidencepeoplecontactsmandatedirect investmentsfund relationshipsco-investorssponsor relationshipsreal estatepublic holdingsrecent eventsprovenancefreshness
Overview
show
Classification
Single family office (confirmed)
Description
••• Locked
Headquarters
••• Locked
Office address
unknown
Business phone
unknown
Website
unknown
Year established
unknown
Assets under management
unknown
Capital scale
Reported office AUM: unknown. No public number of any kind.
Classification history
  • Sep 15, 2026Single family office (confirmed) 85%Wikipedia, independent of the GlobeNewswire A••••••••• source, confirms Athos KG is the single family office of twin brothers T••••• and A•••••• S•••••••••, who built and sold the pharmaceutical company Hexal.Factverifieden.wikipedia.org••• Locked
  • Sep 14, 2026Single family office (probable) 70%a press release by A••••••••• describes it as a single family office (cited)Fact
Family and wealth origin
show
Family served
unknown
Source of wealth
••• Locked
Operating company origin
unknown
Team
4 people, 1 with investment decisions, decision makers firstshow
PersonTitleResponsibilityBusiness contactSource
A•••••• S••••••••• familyPrincipalFamily principal · investment decisionsnone on record
T••••• S••••••••• familyPrincipalFamily principal · investment decisionsnone on record
H••••• J•••••General Partner (Komplementär)Leadershipnone on record
sec.gov Fact
T••••• M••••General Partner (Komplementär)Leadershipnone on record
sec.gov Fact
Signals and timeline
9show

Most significant first: what kind of change it is, its size, whose change it is, and how recent. 9 events. 13F position changes are under Public stakes and holdings.

  • Nov 3, 2025Office discovered••• LockedDiscoveryFactglobenewswire.com
  • Sep 15, 2026Classification changed••• Lockedc•••••••••Facten.wikipedia.org
  • Nov 3, 2025Direct investment••• LockedDirect investmentsFactglobenewswire.com
  • Nov 3, 2025Direct investment••• LockedDirect investmentsFactglobenewswire.com
  • May 10, 2022Direct investment••• LockedDirect investmentsFactformycon.com
Full timeline · 9 events
  • May 10, 2022Direct investment••• LockedDirect investmentsFactformycon.com
  • Jan 1, 2008Direct investment••• LockedDirect investmentsFacten.wikipedia.org
  • Jan 1, 2008Direct investment••• LockedDirect investmentsFacten.wikipedia.org
  • Feb 21, 2005Family liquidity event••• LockedwealthFactstartuprad.io
Investment mandate
show

••• Locked

Stated (their words, cited)
Sectors
Healthcare and life sciences focus Fact globenewswire.com
••• Locked
Invests directly
••• Locked Fact formycon.com
••• Locked
Control preference
••• Locked Fact globenewswire.com
••• Locked
Observed (from the investment record)
States
none Fact
Control
minority (4), majority (1) Fact
Sectors
mRNA/oncology (1), gene therapy (1), solar (1), biosimilars (1) Fact
Subsectors
none Fact
Co investors
A•••• V••••••• (2), C••••••• I•• (2), N••• S•• (2), S•••• D••••• C•••••• (2), X••• V•••••• (2), W•••••• A••••••• (2), S•••••••• C•••••• (1), A•••• V•••••• (1), F•••••• (1), C•• V•••••• C•••••• (1), L••••••• F••• (1), S•••••••• P••••••• (1) Fact
Asset classes
biotechnology (3), renewable energy (1) Fact
Direct vs fund
Fund: 0 · Direct: 5 · Real estate: 0 Fact
Sponsors backed
none Fact
Investment count
5 Fact
Investment kinds
anchor equity investment (1), Series B (1), capital increase underwriting (1), equity stake / asset acquisition (1), round participation (1) Fact
First and last deal
Last: 2025-11-03 · First: 2008-01-01 Fact
Lead vs participant
lead (2), participant (2), unknown (1) Fact
Disclosed check sizes
Max: unknown · Min: unknown · Count: 0 Fact
••• Locked
Inferred (regulatory shape and team)
Nothing to infer from.
Invests directly
A•••• invests directly in companies with a long-term, entrepreneurial technology focus
Allocates to managers
unknown
Asset classes
unknown
Sectors
Healthcare and life sciences focus
Geography
unknown
Check size
unknown
Direct investments
5 dealsshow
DateCompanyKindSectorRoleAmountWithSource
Nov 3, 2025A••••••••• B••Series Bgene therapyparticipant · minorityunknownS•••••••• C•••••• (co investor), A•••• V•••••• (co investor), F•••••• (co investor), A•••• V••••••• (co investor), C•• V•••••• C•••••• (co investor), C••••••• I•• (co investor), N••• S•• (co investor), S•••• D••••• C•••••• (co investor), X••• V•••••• (co investor), W•••••• A••••••• (co investor), L••••••• F••• (co investor), S•••••••• P••••••• (co investor)
••• Locked
Nov 3, 2025A•••••••••Round participationunknownparticipant · minorityunknown
round $141M
A•••• V••••••• (co investor), C•• V•••••• C•••••• t•••••• i•• L•••• V••••••• F••• (co investor), C••••••• I•• (co investor), N••• S•• (co investor), S•••• D••••• C•••••• (co investor), X••• V•••••• (co investor), W•••••• A••••••• (co investor)
••• Locked
May 10, 2022F••••••• A•Equity stake / asset acquisitionbiosimilarslead · minorityunknownnone named
••• Locked
Jan 1, 2008C••••••Capital increase underwritingsolarunknown · minorityunknownnone named
••• Locked
Jan 1, 2008B••••••• S•Anchor equity investmentmRNA/oncologylead · majorityunknownnone named
••• Locked
Fund and manager relationships
show
No fund commitment or manager relationship on the record. Commitment amounts are shown only when public.
Public stakes and holdings
show
Form 13F holdings
No 13F filing on the record for this office.
Real estate
show
No documented real estate ownership link. A property is attributed to an office only through a documented control relationship, never from a surname.
Co-investors
14show
CounterpartyKindShared dealsFirst, lastExamplesSource
A•••• V•••••••organisation2Nov 3, 2025A•••••••••, A••••••••• B••globenewswire.com
S•••• D••••• C••••••organisation2Nov 3, 2025A•••••••••, A••••••••• B••globenewswire.com
X••• V••••••organisation2Nov 3, 2025A•••••••••, A••••••••• B••globenewswire.com
N••• S••organisation2Nov 3, 2025A••••••••• B••, A•••••••••globenewswire.com
C••••••• I••organisation2Nov 3, 2025A••••••••• B••, A•••••••••globenewswire.com
All 14 co-investorsmost shared deals first
CounterpartyKindShared dealsFirst, lastExamplesSource
C•• V•••••• C••••••organisation1Nov 3, 2025A••••••••• B••globenewswire.com
C•• V•••••• C•••••• t•••••• i•• L•••• V••••••• F•••organisation1Nov 3, 2025A•••••••••globenewswire.com
L••••••• F•••organisation1Nov 3, 2025A••••••••• B••globenewswire.com
W•••••• A•••••••family office1Nov 3, 2025A•••••••••globenewswire.com
W•••••• A•••••••organisation1Nov 3, 2025A••••••••• B••globenewswire.com
S•••••••• P•••••••organisation1Nov 3, 2025A••••••••• B••globenewswire.com
S•••••••• C••••••organisation1Nov 3, 2025A••••••••• B••globenewswire.com
A•••• V••••••organisation1Nov 3, 2025A••••••••• B••globenewswire.com
F••••••organisation1Nov 3, 2025A••••••••• B••globenewswire.com
  • S•••••••• P••••••• Nov 3, 2025 recurring (2) Fact globenewswire.com
  • L••••••• F••• Nov 3, 2025 recurring (2) Fact globenewswire.com
  • W•••••• A••••••• Nov 3, 2025 recurring (2) Fact globenewswire.com
  • X••• V•••••• Nov 3, 2025 strong (4) Fact globenewswire.com
  • S•••• D••••• C•••••• Nov 3, 2025 strong (4) Fact globenewswire.com
All 38 co-investment links
  • N••• S•• Nov 3, 2025 strong (4) Fact globenewswire.com
  • C••••••• I•• Nov 3, 2025 strong (4) Fact globenewswire.com
  • C•• V•••••• C•••••• Nov 3, 2025 recurring (2) Fact globenewswire.com
  • A•••• V••••••• Nov 3, 2025 strong (4) Fact globenewswire.com
  • F•••••• Nov 3, 2025 recurring (2) Fact globenewswire.com
  • A•••• V•••••• Nov 3, 2025 recurring (2) Fact globenewswire.com
  • S•••••••• C•••••• Nov 3, 2025 recurring (2) Fact globenewswire.com
  • S•••••••• P••••••• Nov 3, 2025 recurring (2) Fact globenewswire.com
  • L••••••• F••• Nov 3, 2025 recurring (2) Fact globenewswire.com
  • W•••••• A••••••• Nov 3, 2025 recurring (2) Fact globenewswire.com
  • X••• V•••••• Nov 3, 2025 strong (4) Fact globenewswire.com
  • S•••• D••••• C•••••• Nov 3, 2025 strong (4) Fact globenewswire.com
  • N••• S•• Nov 3, 2025 strong (4) Fact globenewswire.com
  • C••••••• I•• Nov 3, 2025 strong (4) Fact globenewswire.com
  • C•• V•••••• C•••••• Nov 3, 2025 recurring (2) Fact globenewswire.com
  • A•••• V••••••• Nov 3, 2025 strong (4) Fact globenewswire.com
  • F•••••• Nov 3, 2025 recurring (2) Fact globenewswire.com
  • A•••• V•••••• Nov 3, 2025 recurring (2) Fact globenewswire.com
  • S•••••••• C•••••• Nov 3, 2025 recurring (2) Fact globenewswire.com
  • W•••••• A••••••• Nov 3, 2025 recurring (2) Fact globenewswire.com
  • X••• V•••••• Nov 3, 2025 strong (4) Fact globenewswire.com
  • S•••• D••••• C•••••• Nov 3, 2025 strong (4) Fact globenewswire.com
  • N••• S•• Nov 3, 2025 strong (4) Fact globenewswire.com
  • C••••••• I•• Nov 3, 2025 strong (4) Fact globenewswire.com
  • C•• V•••••• C•••••• t•••••• i•• L•••• V••••••• F••• Nov 3, 2025 recurring (2) Fact globenewswire.com
  • A•••• V••••••• Nov 3, 2025 strong (4) Fact globenewswire.com
  • W•••••• A••••••• Nov 3, 2025 recurring (2) Fact globenewswire.com
  • X••• V•••••• Nov 3, 2025 strong (4) Fact globenewswire.com
  • S•••• D••••• C•••••• Nov 3, 2025 strong (4) Fact globenewswire.com
  • N••• S•• Nov 3, 2025 strong (4) Fact globenewswire.com
  • C••••••• I•• Nov 3, 2025 strong (4) Fact globenewswire.com
  • C•• V•••••• C•••••• t•••••• i•• L•••• V••••••• F••• Nov 3, 2025 recurring (2) Fact globenewswire.com
  • A•••• V••••••• Nov 3, 2025 strong (4) Fact globenewswire.com
Independent sponsor relationships
show
No cited relationship to an independent sponsor.
Related entities
show
Sources and evidence
23show

Every observation behind this profile: the value, when it was effective, the source, the quote where there is one, and whether it is a fact, an inference or an estimate. 23 shown.

Score components
Freshness
+100 d••• s•••• t•• n••••• s••••••••• f••• o• a•••••• v••••••••• (6 days)
Contactability
+30 n•••• d••••••••• (••• Locked)
Data confidence
+10 d•••••••••
+10 s••••• m••••••
+10 p•••••
+15 i•••••••••
+10 i••••••••• s•••••• (2 sources)
Active deployment
+50 d•••• p•••••• i••••••••• i• l••• 2• m••••• (A••••••••• B•• (2025-11-03); A••••••••• (2025-11-03))
+25 a• d•••• p•••••• i••••••••• i• l••• 1• m••••• (2025-11-03)
Exists confidence
+20 i••••••••• s•••••• (2 sources)
+30 a•••••••••
Research priority
+15 s••••• f••••• o• f••••• i••••••••• c••••••
+15 d••••• i••••••••• o• r•••••
+10 d••••••• i• l••• 2• m•••••
+2 n• w•••••• k•••• •••••••• w•••• f••• o•••
+0 r••• (44)
Mandate confidence
+50 m•••••• s•••••••• b• o••••••• i•••••••••
+20 s••••• m•••••• o• t•• r•••••
Identity confidence
+85 c••••••••• (••• Locked)
Real estate propensity
no components; scored 0
Co investment propensity
+80 c••••••••• o• t•• r••••• (••• Locked)
+20 p••••••••• i• s••••••••• r•••••
Family identity confidence
+60 w••••• o••••• o• o•••••••• c•••••• o• t•• r•••••
+20 f••••• p•••••••• o• s••••
Private markets propensity
no components; scored 0
Current activity confidence
+50 d•••• p•••••• i••••••••• i• 2• m•••••
+25 a• s••••••••• f••• w••••• 1• m••••• (323 days)
External manager propensity
no components; scored 0
Direct investment propensity
+70 o••••••• d••••• i••••••••• (5 on the record)
Independent sponsor propensity
no components; scored 0
View all 23 observations
FactValueEffectiveSourceClass
Control preference••• Locked
••• Locked
Nov 3, 2025DFX analyst research (General-assisted, every claim URL-cited) globenewswire.comFact
Description••• Locked
••• Locked
Sep 16, 2026DFX analyst research (General-assisted, every claim URL-cited) athos-kg.deFact
Description••• Locked
••• Locked
Sep 15, 2026DFX analyst research (General-assisted, every claim URL-cited) athos-kg.deFact
Family involvement••• Locked
••• Locked
Sep 16, 2026DFX analyst research (General-assisted, every claim URL-cited) en.wikipedia.orgFact
Family involvement••• Locked
••• Locked
Sep 15, 2026DFX analyst research (General-assisted, every claim URL-cited) en.wikipedia.orgFact
Family involvement••• Locked
••• Locked
Feb 12, 2020DFX analyst research (General-assisted, every claim URL-cited) sec.govFact
Family wealth estimate••• Locked
••• Locked
Sep 16, 2026DFX analyst research (General-assisted, every claim URL-cited) en.wikipedia.orgEstimate
Family wealth estimate••• Locked
••• Locked
Sep 15, 2026DFX analyst research (General-assisted, every claim URL-cited) en.wikipedia.orgEstimate
Former nameAlso operates/known as Athos Service
••• Locked
Sep 16, 2026DFX analyst research (General-assisted, every claim URL-cited) en.wikipedia.orgFact
Former nameAlso operates/known as Athos Service
••• Locked
Sep 15, 2026DFX analyst research (General-assisted, every claim URL-cited) en.wikipedia.orgFact
Headquarters••• Locked
Bergfeldstraße 9 83607 Holzkirchen
Feb 12, 2020DFX analyst research (General-assisted, every claim URL-cited) sec.govFact
Invests directly••• Locked
••• Locked
Sep 16, 2026DFX analyst research (General-assisted, every claim URL-cited) formycon.comFact
Invests directly••• Locked
••• Locked
Sep 15, 2026DFX analyst research (General-assisted, every claim URL-cited) formycon.comFact
Legal entity••• Locked
••• Locked
Feb 12, 2020DFX analyst research (General-assisted, every claim URL-cited) sec.govFact
Office type (stated)Single family office
••• Locked
Sep 15, 2026DFX analyst research (General-assisted, every claim URL-cited) en.wikipedia.orgFact
Office type (stated)Single family officeNov 3, 2025GlobeNewswire releases that name a family office (discovery and investment records, quoted) globenewswire.comFact
SectorsHealthcare and life sciences focus
••• Locked
Nov 3, 2025DFX analyst research (General-assisted, every claim URL-cited) globenewswire.comFact
Source of wealth••• Locked
••• Locked
Jan 1, 2005DFX analyst research (General-assisted, every claim URL-cited) en.wikipedia.orgFact
Source of wealth••• Locked
••• Locked
Jan 1, 1956DFX analyst research (General-assisted, every claim URL-cited) startuprad.ioFact
Website searchNot foundSep 21, 2026DFX model output (c••••••••• rules, scores, mandates, matches) no URLInference
Website searchNot foundSep 19, 2026DFX model output (c••••••••• rules, scores, mandates, matches) no URLInference
Website searchNot foundSep 16, 2026DFX model output (c••••••••• rules, scores, mandates, matches) no URLInference
Website searchNot foundSep 14, 2026DFX model output (c••••••••• rules, scores, mandates, matches) no URLInference

Not yet on record: capital scale.